<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Advances in Molecular Oncology</journal-id><journal-title-group><journal-title xml:lang="en">Advances in Molecular Oncology</journal-title><trans-title-group xml:lang="ru"><trans-title>Успехи молекулярной онкологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-805X</issn><issn publication-format="electronic">2413-3787</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">168</article-id><article-id pub-id-type="doi">10.17650/2313-805X-2018-5-3-75-82</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>RESEARCH ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Interrelation of HPV-infection of endometry carcinoma and its clinical-morphological features</article-title><trans-title-group xml:lang="ru"><trans-title>Взаимосвязь ВПЧ-инфицирования карциномы эндометрия с ее клинико-морфологическими особенностями</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5345-4872</contrib-id><name-alternatives><name xml:lang="en"><surname>Zykova</surname><given-names>T. A.</given-names></name><name xml:lang="ru"><surname>Зыкова</surname><given-names>Т. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>tatiana2904@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4037-7649</contrib-id><name-alternatives><name xml:lang="en"><surname>Moiseenko</surname><given-names>T. I.</given-names></name><name xml:lang="ru"><surname>Моисеенко</surname><given-names>Т. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3618-6890</contrib-id><name-alternatives><name xml:lang="en"><surname>Frantsiyants</surname><given-names>E. M.</given-names></name><name xml:lang="ru"><surname>Франциянц</surname><given-names>Е. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4901-250X</contrib-id><name-alternatives><name xml:lang="en"><surname>Vovkochina</surname><given-names>M. A.</given-names></name><name xml:lang="ru"><surname>Вовкочина</surname><given-names>М. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Rostov Research Institute of Oncology</institution></aff><aff><institution xml:lang="ru">ФГБУ «Ростовский научно-исследовательский онкологический институт» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-09-15" publication-format="electronic"><day>15</day><month>09</month><year>2018</year></pub-date><volume>5</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>75</fpage><lpage>82</lpage><history><date date-type="received" iso-8601-date="2018-11-10"><day>10</day><month>11</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2018-11-10"><day>10</day><month>11</month><year>2018</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Zykova T.A., Moiseenko T.I., Frantsiyants E.M., Vovkochina M.A.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Зыкова Т.А., Моисеенко Т.И., Франциянц Е.М., Вовкочина М.А.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Zykova T.A., Moiseenko T.I., Frantsiyants E.M., Vovkochina M.A.</copyright-holder><copyright-holder xml:lang="ru">Зыкова Т.А., Моисеенко Т.И., Франциянц Е.М., Вовкочина М.А.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://umo.abvpress.ru/jour/article/view/168">https://umo.abvpress.ru/jour/article/view/168</self-uri><abstract xml:lang="en"><p>Background. There are contradictory data on the detection of human papillomavirus (HPV) in the tumor tissue in endometrial cancer (EС). Objective: to assess HPV infection rates in EC tumor tissues and to establish the relationship between the status of HPV infection and tumor morphological characteristics. Materials and methods. 57 formalin-fixed paraffin-embedded (FFPE) tissue samples of EC patients aged 47–78 years were studied. HPV DNAs were found in 54.4 % of samples. Results and conclusion. We did not reveal an association between the HPV tumor status and age, metastasis or invasion depth. However, there was an interdependence between HPV infection and some morphological characteristics of the tumor: its histological type (adenocarcinomas with squamous cell differentiation were HPV-positive 1.8 times more frequent compared to adenocarcinomas without one; in the first case, tumor tissues were more often infected with HPV 16, and in the second case with HPV 18); tumor grade (in the total cohort and in serous-papillary adenocarcinomas, tumors with higher grades were more often HPV-infected: from 0 to 81.8 % and from 0 to 100 % respectively); disease stage (in the total cohort the percentage of HPV-positive tumors in stage II was 2.4 times and in stage III – 1.6 times higher than in stage I, and stage IA tumors were HPV-positive 2.3 times more often than IB tumors); type of tumor growth (tumors with infiltrative growth type were HPV-positive 1.7 times more often than with exophytic growth, and 2.2 times more often than with mixed growth). The achieved results do not allow us to conclude with confidence that HPV is the main tumor forming factor in EC.</p></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>endometrial cancer</kwd><kwd>human papillomavirus</kwd><kwd>real-time polymerase chain reaction</kwd><kwd>HPV infection rates</kwd><kwd>genotype</kwd><kwd>viral load</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>рак эндометрия</kwd><kwd>вирус папилломы человека</kwd><kwd>полимеразная цепная реакция в реальном времени</kwd><kwd>распространенность ВПЧ</kwd><kwd>генотип</kwd><kwd>вирусная нагрузка</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Ferlay J., Soerjomataram I., Ervik M. et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Available at: http://globocan.iarc.fr.</mixed-citation></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Kostin A.A., Starinskiy V.V., Samsonov Yu.V., Asratov A.T. The analysis of statistical data on malignant neoplasms associated with human papillomavirus. Issledovaniya i praktika v meditsine = Research and Practice in Medicine 2016;3(1):66–78. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Костин А.А., Старинский В.В., Самсонов Ю.В., Асратов А.Т. Анализ статистических данных о злокачественных новообразованиях, ассоциированных с вирусом папилломы человека. Исследования и практика в медицине 2016;3(1):66–78.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><mixed-citation>A review of human carcinogens. B. Biological agents. IARC Monograph on the Evaluation of Carcinogenic Risk to Humans. Vol. 100(B). 2012. 485 p.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Giatromanolaki A., Sivridis E., Papazoglou D. et al. Human papillomavirus in endometrial adenocarcinomas: infectious agent or a mere “passenger”? Infect Dis Obstet Gynecol 2007;2007:60549. DOI: 10.1155/2007/60549. PMID: 18274613.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Fedrizzi E.N., Villa L.L., de Souza I.V. et al. Does human papillomavirus play a role in endometrial carcinogenesis? Int J Gynecol Pathol 2009;28(4):322–7. DOI: 10.1097/PGP.0b013e318199943b. PMID: 19483634.</mixed-citation></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Babaeva N.A. Hormonal and infectious factors of carcinogenesis of organs of the female reproductive system. Thesis … of doctor of medical sciences. Moscow, 2013. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Бабаева Н.А. Гормональный и инфекционный факторы канцерогенеза органов женской репродуктивной системы. Дис. ... д-ра мед. наук. М., 2013</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Olesen T.B., Svahn M.F., Faber M.T. et al. Prevalence of Human Papillomavirus in endometrial cancer: a systematic review and meta-analysis. Gynecol Oncol 2014;134(1):206–15. DOI: 10.1016/j.ygyno.2014.02.040. PMID: 24607284.</mixed-citation><mixed-citation xml:lang="ru">Olesen T.B., Svahn M.F., Faber M.T. et al. Prevalence of Human Papillomavirus in endometrial cancer: a systematic review and meta-analysis. Gynecol Oncol 2014;134(1):206–15. DOI: 10.1016/j. ygyno.2014.02.040. PMID: 24607284.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Glantz S. Primer of biostatistics. Мoscow: Praktika, 1999. 459 p. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Гланц С. Медико-биологическая статистика. Пер. с англ. М.: Практика, 1999. 459 с.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><mixed-citation>zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2(5):342–50. DOI: 10.1038/nrc798. PMID: 12044010.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Jiang L., Malpica A., Deavers M.T. et al. Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries. Int J Gynecol Pathol 2010;29(2):146–56. DOI: 10.1097/PGP.0b013e3181b8e951. PMID: 20173500.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Jones M.W., Onisko A., Dabbs D.J. et al. Immunohistochemistry and HPV in situ hybridization in pathologic distinction between endocervical and endometrial adenocarcinoma: a comparative tissue microarray study of 76 tumors. Int J Gynecol Cancer 2013;23(2):380–4. DOI: 10.1097/IGC.0b013e31825cc8ee. PMID: 23318908.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Malpica A. How to approach the many faces of endometrioid carcinoma. Mod Pathol 2016;29 Suppl 1: S29–44. DOI: 10.1038/modpathol. 2015.142. PMID: 26715172.</mixed-citation></ref></ref-list></back></article>
